Abstract
Objectives
Patientswith brain tumours have majordisabilities and guarded prognosisbut may benefit from inpatient rehabilitation.The objectives were tocompare functional outcomes inpatients with glioblastoma multiforme(GBM), brain metastasesand other brain tumours, and todetermine predictors of survival.
Methods
Demographic, clinical,functional, and survival data werecollected for 63 patients.Kaplan-Meier and Cox regression wereused for survival analyses.
Results
Functional Independence Measure(FIM™) scores improved fromadmission to discharge for patientswith GBM, brain metastases andother tumours. Estimated mediansurvival was 141 days for brainmetastases, 214 days for GBM and439 days for other tumours. Lowadmission dexamethasone doseand high FIM™ gain predictedbetter survival in GBM. For brainmetastases, high FIM™ gain, lowdexamethasone dose and no organmetastases were positive prognosticfactors.
Conclusions
Patientswith primary and metastatic braintumours achieved functional gainsafter rehabilitation. High functionalimprovement is a significantpredictor of longer survival inbrain metastases and GBM. Thisstudy has implications for rehabilitationin the post-acute managementof patients who have disabilitiesdue to brain tumours.
Similar content being viewed by others
References
American Cancer Society (2006)Cancer Facts and Figures 2006. Atlanta:American Cancer Society
DeLisa JA (2001) A history of cancerrehabilitation. Cancer 92:970–974
Lehmann JF, DeLisa JA, Warren CG,deLateur BJ, Bryant PL, Nicholson CG(1978) Cancer rehabilitation: Assessmentof need, development, and evaluationof a model of care. Arch PhysMed Rehabil 59:410–419
Harvey RF, Jellinek HM, Habeck RV(1982) Cancer rehabilitation: An analysisof 36 program approaches. JAMA247:2127–2131
Boake C, Meyers CA (1993) Braintumor rehabilitation: Survey of clinicalpractice. Arch Phys Med Rehabil 74:1247 (abstract)
Kirshblum S, O’Dell MW, Ho C, Barr K(2001) Rehabilitation of persons withcentral nervous system tumors. Cancer92:1029–1038
Huang ME, Cifu DX, Keyser-Marcus L(2000) Functional outcomes in patientswith brain tumor after inpatientrehabilitation: Comparison with traumaticbrain injury. Am J Phys MedRehabil 79:327–335
Huang ME, Cifu DX, Keyser-Marcus L(1998) Functional outcome after braintumor and acute stroke: A comparativeanalysis. Arch Phys Med Rehabil 79:1386–1390
O’Dell MW, Barr K, Spanier D, WarnickRE (1998) Functional outcome of inpatientrehabilitation in persons withbrain tumors. Arch Phys Med Rehabil79:1530–1534
Greenberg E, Treger I, Ring H (2006)Rehabilitation outcomes in patientswith brain tumors and acute stroke:Comparative study of inpatient rehabilitation.Am J Phys Med Rehabil85:568–573
Sherer M, Meyers CA, Bergloff P (1997)Efficacy of postacute brain injury rehabilitationfor patients with primarymalignant brain tumors. Cancer 80:250–257
Huang ME, Wartella JE, Kreutzer JS(2001) Functional outcomes and qualityof life in patients with brain tumors:A preliminary report. Arch PhysMed Rehabil 82:1540–1546
Marciniak CM, Sliwa JA, HeinemannAW, Semik PE (2001) Functional outcomesof persons with brain tumorsafter inpatient rehabilitation. ArchPhys Med Rehabil 82:457–463
Mukand JA, Blackinton DD, CrincoliMG, Lee JJ, Santos BB (2001) Incidenceof neurologic deficits and rehabilitationof patients with brain tumors. AmJ Phys Med Rehabil 80:346–350
Lagerwaard FJ, Levendag PC, NowakPJ, Eijkenboom WM, Hanssens PE,Schmitz PI (1999) Identification ofprognostic factors in patients withbrain metastases: A review of 1292patients. Int J Radiat Oncol Biol Phys43:795–803
Korinth MC, Delonge C, Hutter BO,Gilsbach JM (2002) Prognostic factorsfor patients with microsurgically resectedbrain metastases. Onkologie25:420–425
Broadbent AM, Hruby G, Tin MM,Jackson M, Firth I (2004) Survivalfollowing whole brain radiation treatmentfor cerebral metastases: An auditof 474 patients. Radiother Oncol 71:259–265
CBTRUS (Central Brain TumorRegistry of the United States) (2005)Statistical report: Primary brain tumorsin the United States, 1998–2002.Chicago: Central Brain Tumor Registryof the United States
Sathornsumetee S, Rich JN (2006) Newtreatment strategies for malignantgliomas. Expert Rev Anticancer Ther6:1087–1104
Wrensch M, Fisher JL, SchwartzbaumJA, Bondy M, Berger M, Aldape KD(2005) The molecular epidemiology ofgliomas in adults. Neurosurg Focus19:E5
Giannini C, Scheithauer BW, WeaverAL, Burger PC, Kros JM, Mork S, GraeberMB, Bauserman S, Buckner JC,Burton J, Riepe R, Tazelaar HD, NascimentoAG, Crotty T, Keeney GL, PerniconeP, Altermatt H (2001) Oligodendrogliomas:Reproducibility andprognostic value of histologic diagnosisand grading. J Neuropathol ExpNeurol 60:248–262
Milstein JM, Cohen ME, Sinks LF(1985) The influence and reliability ofneurologic assessment and Karnofskyperformance score on prognosis.Cancer 56:1834–1836
Stern JI, Raizer JJ (2006) Chemotherapyin the treatment of malignantgliomas. Expert Rev Anticancer Ther6:755–767
Brazil L, Thomas R, Laing R, Hines F,Guerrero D, Ashley S, Brada M (1997)Verbally administered Barthel Index asfunctional assessment in brain tumourpatients. J Neurooncol 34:187–192
Meyers CA, Hess KR, Yung WK, LevinVA (2000) Cognitive function as a predictorof survival in patients with recurrentmalignant glioma. J Clin Oncol18:646–650
Keith RA, Granger CV, Hamilton BB,Sherwin FS (1987) The functional independencemeasure: A new tool forrehabilitation. Adv Clin Rehabil 1:6–18
Barber MD, Ross JA, Fearon KC (1999)Cancer cachexia. Surg Oncol 8:133–141
Viale PH (2005) Abnormal clotting incancer: An overview of pathophysiologyand etiology. Semin Oncol Nurs21:12–20
Davis, MP, Khoshknabi D, Yue GH(2006) Management of fatigue incancer patients. Curr Pain HeadacheRep 10:260–269
O’Dell MW (1999) Neurorehabilitationin cancer: Brain tumors. RehabilitationOncology 17:32–33
Rubin EH, Hait WN (2003) Principlesof cancer treatment. In: ACP MedicineOncology (online). Available at:www.acpmedicine.com. AccessedNovember 6:2006
Vecht CJ, Hovestadt A, Verbiest HB, vanVliet JJ, van Putten WL (1994) Doseeffectrelationship of dexamethasoneon Karnofsky performance in metastaticbrain tumors: A randomized studyof doses of 4,8, and 16 mg per day.Neurology 44:675–680
Hempen C, Weiss E, Hess CF (2002)Dexamethasone treatment in patientswith brain metastases and primarybrain tumors: Do the benefits outweighthe side-effects? Support CareCancer 10:322–328
Crevenna R, Schmidinger M, KeilaniM, Nuhr M, Fialka-Moser V, Zettinig G,Quittan M (2003) Aerobic exercise fora patient suffering from metastaticbone disease. Support Care Cancer11:120–122
Crevenna R, Fialka-Moser V, Keilani M,Schmidinger M, Marosi C, Quittan M(2002) Aerobic physical training in abreast cancer patient with inflammatoryrecurrence. Wien Med Wochenschr152:581–584
Crevenna R, Schmidinger M, KeilaniM, Nuhr M, Nur H, Zoch C, Zielinski C,Fialka-Moser V, Quittan M (2003)Aerobic exercise as additive palliativetreatment for a patient with advancedhepatocellular cancer. Wien MedWochenschr 153:237–240
Oldervoll LM, Loge JH, Paltiel H, AspMB, Vidvei U, Wiken AN, HjermstadMJ, Kaasa S (2006) The effect of aphysical exercise program in palliativecare: A phase II study. J Pain SymptomManage 31:421–430
Headley JA, Ownby KK, John LD(2004) The effect of seated exercise onfatigue and quality of life in womenwith advanced breast cancer. OncolNurs Forum 31:977–983
Davis JM, Kohut ML, Jackson DA,Colbert LH, Mayer EP, Ghaffar A(1998) Exercise effects on lung tumormetastases and in vitro alveolarmacrophage antitumor cytotoxicity.Am J Physiol 274:R1454–R1459
Fairey AS, Courneya KS, Field CJ, BellGJ, Jones LW, Mackey JR (2005) Randomizedcontrolled trial of exerciseand blood immune function in postmenopausalbreast cancer survivors.J Appl Physiol 98:1534–1540
Jadeski L, Hoffman-Goetz L (1996) Exerciseand in vivo natural cytotoxicityagainst tumour cells of varyingmetastatic capacity. Clin Exp Metastasis14:138–144
MacNeil B, Hoffman-Goetz L (1993)Effect of exercise on natural cytotoxicityand pulmonary tumour metastasesin mice. Med Sci Sports Exerc 25:922–928
Murphy EA, Davis JM, Brown AS,Carmichael MD, Mayer EP, Ghaffar A(2004) Effects of moderate exerciseand oat beta-glucan on lung tumormetastases and macrophage antitumorcytotoxicity. J Appl Physiol 97:955–959
Jones LW, Guill B, Keir ST, Carter BS,Friedman HS, Bigner DD, Reardon DA(2006) Patterns of exercise across thecancer trajectory in brain tumor patients.Cancer 106:2224–2232
Davidoff GN, Roth EJ, Haughton JS,Ardner MS (1990) Cognitive dysfunctionin spinal cord injury patients:sensitivity of the Functional IndependenceMeasure subscales vs neuropsychologicassessment. Arch Phys MedRehabil 71:326–329
Corrigan JD, Smith-Knapp K, GrangerCV (1997) Validity of the functionalindependence measure for personswith traumatic brain injury. Arch PhysMed Rehabil 78:828–834
Author information
Authors and Affiliations
Corresponding author
Additional information
Function scores noted are based on data collectedusing the FIM™ instrument. The 18-item FIM™ Instrument is the property of theUniform Data System for Medical Rehabilitation,a division of UB Foundation Activities,Inc.
Rights and permissions
About this article
Cite this article
Tang, V., Rathbone, M., Park Dorsay, J. et al. Rehabilitation in primary and metastatic brain tumours. J Neurol 255, 820–827 (2008). https://doi.org/10.1007/s00415-008-0695-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0695-z